SCHEMBL8970632

SCHEMBL8970632

CCCNCC1CCc2ccccc2O1

nearest known ligand 0.69

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 10/20 0.64
HTR1D P28221 10/20 0.64
POLB P06746 1/20 0.59
ESR2 Q92731 1/20 0.59
CA2 P00918 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27471154 0.88 HTR1A (0.60) HTR1AHTR1DCA2
SCHEMBL27478384 0.85 HTR1A (0.64) HTR1AHTR1DCA2
SCHEMBL7201735 0.85 HTR1A (0.64) HTR1AHTR1DCA2
SCHEMBL8052654 0.83 HTR1A (0.66) HTR1AHTR1DCA2
SCHEMBL8864373 0.83 HTR1A (0.66) HTR1AHTR1DCA2
SCHEMBL8049371 0.82 HTR1A (0.60) HTR1AHTR1DCA2
SCHEMBL8879867 0.82 HTR1A (0.60) HTR1AHTR1DCA2
SCHEMBL6921396 0.81 CA2 (0.62) HTR1AHTR1DCA2
SCHEMBL27369359 0.81 HTR1A (0.56) HTR1AHTR1DCA2
SCHEMBL5723599 0.81 HTR1A (0.67) HTR1AHTR1DCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
EP-0352613-B1 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1994-04-20 EP disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed
EP-0352613-A2 Substituted amino methyl tetralines, and their heterocyclic analogous compounds BAYER AG (DE) 1990-01-31 EP disclosed